Skip to content

HeartStart HS1 Defibrillator* Event Registry

HeartStart HS1 Defibrillator* Event Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04840797
Enrollment
1400
Registered
2021-04-12
Start date
2021-02-25
Completion date
2030-12-31
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden Cardiac Arrest

Keywords

AED, Post -Market, Cardiology

Brief summary

A Prospective study on the performance and safety of the HeartStart OnSite (Model M5066A) & HeartStart Home (Model M5068A) Defibrillator device data.

Detailed description

The objective of this PMCF (Post Market Clinical Follow-up) prospective collection of post-event data registry is to confirm the safety and performance as expressed in the energy delivery by the HeartStart HS1 Defibrillator (HeartStart OnSite and Home models in North America) in the population for the device's intended use in reference to its commercial labeling, and in relationship to the type of pads attached to the device.

Interventions

DEVICEHeartStart HS1

Automated External Defibrillator

Sponsors

Heartstream US LLC
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Have been suspected of a circulatory arrest for any cause. * Have had HeartStart HS1 Defibrillator with electrodes: Adult SMART Pads Cartridge \[REF: M5071A\], Infant/Child SMART Pads Cartridge (REF:M5072A) applied to their body and powered up with HS1 battery (Model M5070A), regardless of whether a defibrillation shock was delivered

Exclusion criteria

* Subjects will be excluded if any of the following are present: * AED or pad use other than the HeartStart HS1 Defibrillator with above referenced Philips electrode pads. Note: Use of a device other than the Philips HeartStart HS1 AED does not preclude enrollment if the AED or an Advanced Life Support defibrillator was used after the HeartStart HS1 AED. * AED used for training purposes.

Design outcomes

Primary

MeasureTime frameDescription
Mean shock energy delivered in the pediatric populationUp to 15 minutes during device placementMean of shock energy delivered, when the pediatric defibrillation pads were attached to the AED as intended for infants and children under 25 kilograms / 55 pounds or 0-8 years old.
Mean shock energy delivered in the adult populationUp to 15 minutes during device placementMean of shock energy delivered, when the adult defibrillation pads were attached to the AED as intended for in children and adults over 25 kilograms / 55 pounds or greater than 8 years old.
The Patient Analysis System (PAS) shock advisory algorithm performance as determined by evaluation of the ECG as aligned with the device advisement.Up to 15 minutes during device placementPerformance is defined by the sensitivity and specificity; positive predictive value and false positive rate will be reported for each rhythm category (as defined by device labeling).
Accurate detection of shockable rhythms and facilitation of shocks.Up to 15 minutes during device placementThe percentage of events where a shockable rhythm was identified by the device, the device advised a shock, and the device delivered a shock when the shock button was pressed.
Defibrillation successUp to 15 minutes during device placementDefibrillation success and the number of shocks required for success.

Secondary

MeasureTime frameDescription
Frequency and severity of unexpected adverse eventsUp to 15 minutes during device placementFrequency and severity of unexpected adverse events
Unanticipated adverse device effects (UADE)Up to 15 minutes during device placementUnanticipated adverse device effects (UADE)
Median operating time intervalsUp to 15 minutes during device placementMedian operating time intervals
Routine self-test performance/Battery Insertion self-test performanceUp to 15 minutes during device placementRoutine self-test performance/Battery Insertion self-test performance
Device arming after shock advisement.Up to 15 minutes during device placementThe percentage of events where the device advised a shock and the device armed.
Energy delivered consistent with device labelingUp to 15 minutes during device placementThe percentage of defibrillations in which the energy delivered was consistent with device labeling.
Pad replacement notificationUp to 15 minutes during device placementNumber of events in which pads were replaced at any time during the event after the user is prompted to do so by the device
Shock button effectively pressed after shock advisementUp to 15 minutes during device placementThe percentage of events where a shock was recommended by the device and the shock button was pressed.
Indicators of battery status/depletion (device logged data)Up to 15 minutes during device placementPercentage of events that include indicators of battery status/depletion (device logged data)
Aborted shocks because of low or high impedanceUp to 15 minutes during device placementPercentage of aborted shocks because of low or high impedance
CPR guidance initiated (i-button pushed)Up to 15 minutes during device placementPercentage of events where CPR guidance was initiated (i-button pushed)
CPR activityUp to 15 minutes during device placementPercentage of events where CPR is performed during CPR guidance

Countries

United States

Contacts

CONTACTChase Wennick
chase.wennick@philips.com617-398-7347
CONTACTBarbara Fink
barb.fink@philips.com724-708-7048
PRINCIPAL_INVESTIGATORGerrit Noordergraaf, MD PhD

Philips Healthcare

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026